Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention

Chest

Volumn 147, Issue 3, 2015, Pages 708-718

  Wu, Xiaofan ^a   Lv, Shuzheng ^a   Yu, Xiaohong ^b   Yao, Linyin ^a   Mokhlesi, Babak ^b   Wei, Yongxiang ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; THIENOPYRIDINE DERIVATIVE;

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SLEEP DISORDERED BREATHING; CEREBROVASCULAR DISORDERS; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; REOPERATION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; CEREBROVASCULAR DISORDERS; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84924918446     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-1634     Document Type: Article

References (42)

1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleepdisordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230-1235.
2. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation. 2008;118(10):1080-1111.
3. Sanchez-de-la-Torre M, Campos-Rodriguez F, Barbe F. Obstructive sleep apnoea and cardiovascular disease. Lancet Respir Med. 2013;1(1):61-72.
4. Kohler M, Stradling JR. Crosstalk proposal: most of the cardiovascular consequences of OSA are due to increased sympathetic activity. J Physiol. 2012;590(pt 12):2813-2815.
5. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 2003;107(8):1129-1134.
6. Jelic S, Padeletti M, Kawut SM, et al. Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation. 2008;117(17):2270-2278.
7. Kohler M, Craig S, Nicoll D, Leeson P, Davies RJ, Stradling JR. Endothelial function and arterial stiffness in minimally symptomatic obstructive sleep apnea. Am J Respir Crit Care Med. 2008;178(9):984-988.
8. Jelic S, Lederer DJ, Adams T, et al. Vascular inflammation in obesity and sleep apnea. Circulation. 2010;121(8):1014-1021.
9. Jelic S, Lederer DJ, Adams T, et al. Endothelial repair capacity and apoptosis are inversely related in obstructive sleep apnea. Vasc Health Risk Manag. 2009;5:909-920.
10. Kheirandish-Gozal L, Bhattacharjee R, Kim J, Clair HB, Gozal D. Endothelial progenitor cells and vascular dysfunction in children with obstructive sleep apnea. Am J Respir Crit Care Med. 2010; 182 (1):92-97.
11. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med. 2007;176(7):706-712.
12. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378-1384.
13. Marin JM, Agusti A, Villar I, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012; 307 (20):2169-2176.
14. Mehra R. , BenjaminE.J., ShaharE., et al; Sleep Health Study. Association of nocturnal arrhythmias with sleepdisordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006; 173 (8):910-916.
15. Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004; 110 (4):364-367.
16. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoeahypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005; 365 (9464):1046-1053.
17. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment:a cohort study. Ann Intern Med. 2012; 156 (2):115-122.
18. Gami AS, Howard DE, Olson EJ, Somers VK. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med. 2005; 352 (12):1206-1214.
19. Gami AS, Olson EJ, Shen WK, et al. Obstructive sleep apnea and the risk of sudden cardiac death:a longitudinal study of 10,701 adults. J Am Coll Cardiol. 2013; 62 (7):610-616.
20. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality:a prospective cohort study. PLoS Med.2009;6(8):e1000132.
21. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin Sleep Cohort. Sleep. 2008;31(8):1071-1078.
22. Glantz H, Thunström E, Herlitz J, et al. Occurrence and predictors of obstructive sleep apnea in a revascularized coronary artery disease cohort. Ann Am Thorac Soc. 2013; 10 (4):350-356.
23. Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007;99(1):26-30.
24. Steiner S, Schueller PO, Hennersdorf MG, Behrendt D, Strauer BE. Impact of obstructive sleep apnea on the occurrence of restenosis after elective percutaneous coronary intervention in ischemic heart disease. Respir Res. 2008;9:50.
25. Fernandes NM, Nield LE, Popel N, et al. Symptoms of disturbed sleep predict major adverse cardiac events after percutaneous coronary intervention. Can J Cardiol. 2014; 30 (1):118-124.
26. Buchner S, Satzl A, Debl K, et al. Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction. Eur Heart J. 2014; 35 (3):192-199.
27. Lee CH, Khoo SM, Chan MY, et al. Severe obstructive sleep apnea and outcomes following myocardial infarction. J Clin Sleep Med. 2011;7(6):616-621.
28. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea:results of a meta-analysis. Arch Intern Med. 2003; 163 (5):565-571.
29. Berthon-Jones M, Sullivan CE. Time course of change in ventilatory response to CO2 with long-term CPAP therapy for obstructive sleep apnea. Am Rev Respir Dis. 1987; 135 (1):144-147.
30. Cassar A, Morgenthaler TI, Lennon RJ, Rihal CS, Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death aft er percutaneous coronary intervention. J Am Coll Cardiol. 2007; 50 (14):1310-1314.
31. Chinese Society of Respiratory Diseases Branch of the Sleep-Related Breathing Disorders Study Group. Diagnosis and treatment of obstructive sleep apneahypopnea syndrome guideline (draft). Chin J Tuberc Respir Dis. 2002; 25 (4):195-198.
32. Chinese Society of Respiratory Diseases Branch of the Sleep-Related Breathing Disorders Study Group. Diagnosis and treatment of obstructive sleep apneahypopnea syndrome guideline (2011, revised edition). Chin J Tuberc Respir Dis. 2012; 35 (1):9-12.
33. Garcia-Rio F, Alonso-Fernandez A, Armada E, et al. CPAP effect on recurrent episodes in patients with sleep apnea and myocardial infarction. Int J Cardiol. 2013;168(2):1328-1335.
34. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease:a long-term follow-up study. Eur Heart J. 2004; 25(9):728-734.
35. Barbe F, Duran-Cantolla J, Sanchez-de-la-Torre M, et al Spanish Sleep and Breathing Network. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea:a randomized controlled trial. JAMA. 2012;307(20):2161-2168.
36. Stolker JM, Cohen DJ, Kennedy KF, et al Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Investigators. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012;5 (6):772-782.
37. Wu XF, Chen Y, Liu H, et al. Comparison of long-term (4-year) outcomes of patients with unprotected left main coronary artery narrowing treated with drug-eluting stents vs coronaryartery bypass grafting. Am J Cardiol. 2010;105(12):1728-1734.
38. Pu J, Mintz GS, Biro S, et al. Insights into echo-attenuated plaques, echolucent plaques, and plaques with spotty calcification:novel findings from comparisons among intravascular ultrasound, near-infrared spectroscopy, and pathological histology in 2,294 human coronary artery segments. J Am Coll Cardiol. 2014;63(21):2220-2233.
39. Wu XF, Guo CJ, Chi YP, et al. Attenuated plaque is associated with plaque prolapse accompanied with cardiac enzyme elevation after drug-eluting stent implantation. Coron Artery Dis. 2014;25(1):4-9.
40. Stone GW, Maehara A, Lansky AJ, et al PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364(3):226-235.
41. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence:its importance in cardiovascular outcomes. Circulation. 2009;119(23):3028-3035.
42. Villar I, Izuel M, Carrizo S, Vicente E, Marin JM. Medication adherence and persistence in severe obstructive sleep apnea. Sleep. 2009;32(5):623-628.